Delayed generalized inflammatory psoriasis flare during efalizumab treatment.
B
B
Martin
J L
JL
Sánchez-Carazo
A
A
Pérez-Ferriols
V
V
Oliver
V
V
Alegre
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D015535:Arthritis, Psoriatic / Q000139:chemically induced* / Q000000981:diagnostic imaging; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy*; D011877:Radionuclide Imaging; D013997:Time Factors; D055815:Young Adult
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; C472181:efalizumab